Novel Medical Device for Pharmacological Therapy

Launched by FUNDACION MIGUEL SERVET · Apr 14, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a new medical device designed to improve how intravenous (IV) therapies are managed. Intravenous therapy is a common treatment that delivers medications directly into a patient's bloodstream, often used in intensive care units. The goal of the trial is to see if this new device can help reduce complications, like infections or malfunctions, that can occur with IV therapy. A group of experts in critical care and engineering collaborated to create this device, ensuring it meets the needs of patients and healthcare providers.

To participate in the trial, patients must be admitted to the intensive care unit and willing to give their permission to join the study. However, individuals with certain conditions, such as bleeding disorders or active infections, will not be eligible. Participants can expect to use the new device as part of their treatment and will be monitored to see how well it works. Overall, this trial aims to enhance the safety and effectiveness of IV therapies for patients in critical care.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • patients admitted to the intensive care unit
• • patients with authorization to take part in the study
• Exclusion Criteria:
• • Patients with pre-existing medical conditions: Patients with diseases affecting coagulation, such as hemophilia or thrombocytopathies, could be excluded.
• • Active infection patients: Any patient with vascular access site infections or systemic infections may be excluded to avoid complications.
• • Inability to give informed consent: Patients who are unable to understand or consent to participate in the study.